Tactile Systems Technology (TCMD) Capital Expenditures Growth (1y) (2016 - 2026)
Tactile Systems Technology (TCMD) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | -47.73% |
| 10 | Tactile Systems Technology | 629.79 Mn | 539.60 Mn | 57.61 Mn | 116.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.62% |
| Dec 31, 2025 | 10.87% |
| Sep 30, 2025 | 18.11% |
| Jun 30, 2025 | -26.20% |
| Mar 31, 2025 | -21.37% |
| Dec 31, 2024 | -48.89% |
| Sep 30, 2024 | 149.34% |
| Jun 30, 2024 | -37.66% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 1,736.73% |
| Sep 30, 2023 | -72.79% |
| Jun 30, 2023 | 301.00% |
| Mar 31, 2023 | 83.97% |
| Dec 31, 2022 | -94.44% |
| Sep 30, 2022 | 126.54% |
| Jun 30, 2022 | -43.50% |
| Mar 31, 2022 | -47.39% |
| Dec 31, 2021 | 102.29% |
| Sep 30, 2021 | -35.83% |
| Jun 30, 2021 | 17.22% |